PT Sentosa Karya Gemilang (Indonesia)

Sentosa Karya Gemilang is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1997. Sentosa Karya Gemilang was founded by a group of visionary entrepreneurs with a mission to improve healthcare accessibility and quality in Indonesia. The company has established itself as a key player in the Indonesian pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The primary business line of Sentosa Karya Gemilang is the production of generic drugs, while its secondary business line includes the development of over-the-counter (OTC) medications and health supplements. The company operates several manufacturing facilities across Indonesia, ensuring a robust local geographical footprint. Sentosa Karya Gemilang's main product types include antibiotics, analgesics, and cardiovascular drugs, marketed under well-known brand names such as Sentocare and Gemiphar. The company has expanded its operations beyond Indonesia, exporting its products to several Southeast Asian countries, thereby establishing a modest global footprint. In collaboration with international pharmaceutical companies, Sentosa Karya Gemilang engages in joint ventures to enhance its research and development capabilities. The company is a member of the Indonesian Pharmaceutical Association, actively participating in initiatives to promote industry standards and innovation. Sentosa Karya Gemilang is committed to sustainable growth and aims to become a leading pharmaceutical company in the region. Its vision is to provide high-quality, affordable healthcare solutions to improve the well-being of communities across Southeast Asia.